摘要 |
The use of L-lysine in the manufacture of a medicament for the prophylaxis and treatment of hair loss in humans, particularly telogen effluvium, is provided. A kit is also provided which includes a plurality of separate containers, each containing at least one active agent useful in a combination therapy for the treatment of genetic hair loss, wherein said kit includes L-lysine and at least further active agent selected from minoxidil, anti-androgens, 5.alpha.reductase inhibitors, aromatase inhibitors and corticosteroids.
|